News

Sun Pharma Advanced Research jumps 11%, extends 2-day rally as US court clears Sezaby PRV

Sun Pharma Advanced Research Company surged for a second straight session after a U.S. court ruled in its favour on the Sezaby Priority Review Voucher. The stock jumped over 11%, extending Tuesdays 20% rally, even as analysts caution about overbought technicals and continued quarterly losses.